Six-month outcomes from the Ventricular Catheter Ablation Study, the first-in-human evaluation of its FieldForce Ablation ...
Background: Unlike the tremendous progress made in atrial fibrillation ablation, the greatest unmet clinical need is for innovative ablation treatments for scar-related ventricular tachycardia (VT) – ...
Adagio Medical (ADGM) announced preliminary acute safety and efficacy results from Adagio’s FULCRUM-VT Study evaluating Ultralow Temperature ...
Patients with ventricular tachycardia and ischemic cardiomyopathy are at high risk for adverse outcomes. Catheter ablation is commonly used when antiarrhythmic drugs do not suppress ventricular ...
Medical Device Network on MSN
Adagio Medical reports findings from ventricular tachycardia study
Adagio Medical has reported preliminary acute efficacy and safety findings from its FULCRUM-VT Study, assessing the ULTC for ...
The electrophysiologic mechanism may be due to either enhanced automaticity or triggered activity. In contrast to the paroxysmal variety, the nonparoxysmal type develops gradually and disappears ...
Ablation, a procedure to treat abnormal electrical short circuits caused by a heart attack and is usually reserved for patients who do not improve with medication, may be a better first-line treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback